BioSpace News Archive

The Novartis subsidiary said it plans to offer jobs to the 150 employees currently working at the Colorado facility and add additional headcount there in the future.

The vast majority of Americans are happy at their jobs, according to a new survey conducted by CNBC and Survey Monkey. A BioSpace poll shows that a lot of people in the life sciences industries are not happy at work.

The American Association for Cancer Research (AACR) Annual Meeting is taking place in Atlanta. Here’s a look at just a few stories coming out of the meeting.

The Lead Discovery Center and the Korean Drug Development Fund have entered into an agreement to facilitate the interaction between LDC and the prospering South Korean biotech scene.

In 1979, Evonik launched the thermoplastic elastomer polyether block amide (PEBA) under the brand name VESTAMID® E from its largest global production site in the Marl Chemical Park.

Maintenance treatment with the PARP inhibitor rucaparib was well tolerated and provided clinical responses among patients with advanced BRCA- or PALB2- mutated pancreatic cancer sensitive to platinum-based chemotherapy, according to results from an interim analysis of an ongoing phase II clinical trial presented at the AACR Annual Meeting 2019, March 29–April 3.

GLG Life Tech Corporation, a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and twelve months ended December 31, 2018.

Masy BioServices announced it has acquired Metrology Laboratories Inc., a calibration services provider located in Rockaway, New Jersey.

CENTOGENE announced that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected Non-Executive Chairman. His appointment is effective April 1, 2019.

The U.S. Food and Drug Administration (FDA) approved ADMA Biologics’ Asceniv to treat Primary Humoral Immunodeficiency Disease (PIDD or PI) in adults and adolescents.